Literature DB >> 11913882

Primary orbital melanoma masquerading as vascular anomalies.

V Lee1, C Sandy, G E Rose, I M Moseley, I Cree, J L Hungerford.   

Abstract

PURPOSE: To review two cases of primary orbital melanoma presenting like orbital vascular anomalies.
METHODS: Retrospective review of clinical presentation, treatment, radiology and pathology for two patients under the care of the Orbital Clinic at Moorfields Eye Hospital.
RESULTS: Both lesions presented with the appearance and behaviour of vascular anomalies. In one case, a spindle cell melanoma appeared to be a low flow vascular anomaly with a loculated secondary haemorrhage and, in the other case, a melanoma of soft parts was considered to be an arteriovenous malformation and responded partially to embolisation.
CONCLUSION: Primary malignant melanoma may present as a secondary vascular lesion of the orbit and this very rare tumour should be considered in the differential diagnosis of any vascular anomaly.

Entities:  

Mesh:

Year:  2002        PMID: 11913882     DOI: 10.1038/sj.eye.6700025

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  4 in total

1.  Melanoma-Associated Spongiform Scleropathy in Oculodermal Melanocytosis with Primary Orbital Melanoma.

Authors:  Roshni U Ranjit; Ilya M Leyngold; Curtis E Margo
Journal:  Ocul Oncol Pathol       Date:  2016-07-16

2.  Orbital melanoma with calcification: A diagnostic dilemma.

Authors:  Sukhdeep Bains; Usha Kim; R Shanti
Journal:  Indian J Ophthalmol       Date:  2016-12       Impact factor: 1.848

3.  Primary Orbital Melanoma: Presentation, Treatment, and Long-term Outcomes for 13 Patients.

Authors:  Anna M Rose; Philip J Luthert; Channa N Jayasena; David H Verity; Geoffrey E Rose
Journal:  Front Oncol       Date:  2017-12-18       Impact factor: 6.244

4.  Malignant Melanoma within a Cellular Blue Nevi Presenting as a Vascular Malformation and the Connection to Sporadic KRAS Mutations.

Authors:  Felicia Tai; Vitor M Pereira; Sam Babak; Ivan Radovanovic; Shachar Sade; Tara Lynn Teshima
Journal:  Case Rep Dermatol       Date:  2021-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.